Growth of Osteoporosis Drugs Market to be Impacted by Development of Transdermal Drug Delivery System | Technavio

The market will accelerate at a CAGR of almost 5% between 2019-2023

LONDON--()--The report, global osteoporosis drugs market has been added to Technavio’s catalog. It provides a comprehensive analysis of the market, including its global and regional market share as well as market segmentation based on product and geography for the forecast period 2019-2023.

To learn more about the global trends impacting the future of market research: Download Free Sample Report

This report on the osteoporosis drugs market includes:

Osteoporosis drugs market analysis and forecast 2019-2023: Features

  • Competitive landscape
  • Market segmentation
    • Product
    • Geography
  • Market drivers
  • Market trends
  • Market challenges
  • Five forces analysis
  • Market landscape
  • Market sizing & forecast

Osteoporosis Drugs Market 2019-2023: Competitive Landscape

  • Vendors covered
  • Vendor classification
    • Amgen Inc.
    • Eli Lilly and Company
    • Novartis AG
    • Pfizer Inc.
    • Radius Health, Inc.

Osteoporosis Drugs Market 2019-2023: Geographic Landscape

  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries

Osteoporosis Drugs Market 2019-2023: Product Landscape

  • Antiresorptive drugs - Market size and forecast 2018-2023
  • Anabolic drugs - Market size and forecast 2018-2023

Register for a free trial today and gain instant access to 10,000+ market research reports.

Technavio's SUBSCRIPTION platform

New drug approvals and favorable pipeline will drive the osteoporosis drugs market

The growing prevalence of osteoporosis is prompting many vendors to increase their R&D efforts to develop novel drugs. Regulatory bodies across the world are also providing marketing approvals for new drugs to combat the prevalence of such bone diseases. For instance, over recent years, the US FDA approved several osteoporosis drugs such as anabolic agents, bone-forming monoclonal antibodies, and others. Many such drugs are currently in the final stages of clinical trials and are expected to receive market approvals during the forecast period. These factors are expected to drive the growth of the global osteoporosis market during the forecast period.

Development of Transdermal Drug Delivery System – An emerging trend in the osteoporosis market

Vendors in the market are focusing on the development of transdermal drugs to overcome certain drawbacks of anabolic agents. For instance, certain vendors are developing abaloparatide transdermal patch to treat postmenopausal osteoporosis in women. Several vendors are working on the development of abaloparatide transdermal patches for other types of osteoporosis diseases that are in various phases of clinical trials. This growing trend among vendors is expected to boost market growth during the forecast period.

Other Key Topics Covered in the Report are:

MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

MARKET SIZING

  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2023

Get Full Report: https://www.technavio.com/report/global-osteoporosis-drugs-market-industry-analysis

CUSTOMER LANDSCAPE

DECISION FRAMEWORK

DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

MARKET TRENDS

  • Increase in strategic alliances
  • Development of transdermal drug delivery system
  • Rising demand for anabolic drugs

Technavio also offers Custom Research services providing focused, comprehensive, and tailored research.

For More Information Click Here

Browse Related Healthcare Reports:

  • Global Bone Sonometers Market: The global bone sonometers market is forecast to grow at a CAGR of almost 6% during the period 2019-2023. The bone sonometers market size will increase by USD 325.97 million during the forecast period of 2019-2023.

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com

Release Summary

The report, global osteoporosis drugs market has been added to Technavio’s catalog.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com